Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1135

1.

A quantitative immunochemical fecal occult blood test for colorectal neoplasia.

Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Leshno M, Niv Y.

Ann Intern Med. 2007 Feb 20;146(4):244-55.

PMID:
17310048
2.

Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection.

Hundt S, Haug U, Brenner H.

Ann Intern Med. 2009 Feb 3;150(3):162-9.

PMID:
19189905
3.

Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test.

Vilkin A, Rozen P, Levi Z, Waked A, Maoz E, Birkenfeld S, Niv Y.

Am J Gastroenterol. 2005 Nov;100(11):2519-25.

PMID:
16279909
4.

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.

Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV.

J Natl Cancer Inst. 2007 Oct 3;99(19):1462-70. Epub 2007 Sep 25.

PMID:
17895475
6.

Quantitative immunochemical fecal occult blood testing for colorectal adenoma detection: evaluation in the target population of screening and comparison with qualitative tests.

Haug U, Hundt S, Brenner H.

Am J Gastroenterol. 2010 Mar;105(3):682-90. doi: 10.1038/ajg.2009.668. Epub 2009 Dec 1.

PMID:
19953091
7.

Cumulative evaluation of a quantitative immunochemical fecal occult blood test to determine its optimal clinical use.

Rozen P, Comaneshter D, Levi Z, Hazazi R, Vilkin A, Maoz E, Birkenfeld S, Niv Y.

Cancer. 2010 May 1;116(9):2115-25. doi: 10.1002/cncr.25012.

8.

Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.

Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Leshno M, Niv Y.

Aliment Pharmacol Ther. 2009 Apr 15;29(8):906-17. doi: 10.1111/j.1365-2036.2009.03946.x.

9.

Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.

van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E.

Gastroenterology. 2008 Jul;135(1):82-90. doi: 10.1053/j.gastro.2008.03.040. Epub 2008 Mar 25.

PMID:
18482589
10.
11.

Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice.

Collins JF, Lieberman DA, Durbin TE, Weiss DG; Veterans Affairs Cooperative Study #380 Group.

Ann Intern Med. 2005 Jan 18;142(2):81-5.

PMID:
15657155
12.

Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?

Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Niv Y.

Aliment Pharmacol Ther. 2006 Nov 15;24(10):1475-81. Epub 2006 Oct 10.

13.

Diagnostic accuracy of immunochemical versus guaiac faecal occult blood tests for colorectal cancer screening.

Parra-Blanco A, Gimeno-García AZ, Quintero E, Nicolás D, Moreno SG, Jiménez A, Hernández-Guerra M, Carrillo-Palau M, Eishi Y, López-Bastida J.

J Gastroenterol. 2010 Jul;45(7):703-12. doi: 10.1007/s00535-010-0214-8. Epub 2010 Feb 17.

PMID:
20157748
14.

[Chemical or immunological tests for the detection of fecal occult blood in colorectal cancer screening?].

Quintero E.

Gastroenterol Hepatol. 2009 Oct;32(8):565-76. doi: 10.1016/j.gastrohep.2009.01.179. Epub 2009 Jul 3. Review. Spanish.

PMID:
19577340
15.

Evaluation of an automated immunochemical fecal occult blood test for colorectal neoplasia detection in a Chinese population.

Wong WM, Lam SK, Cheung KL, Tong TS, Rozen P, Young GP, Chu KW, Ho J, Law WL, Tung HM, Choi HK, Lee YM, Lai KC, Hu WH, Chan CK, Yuen MF, Wong BC.

Cancer. 2003 May 15;97(10):2420-4.

17.

Sensitivity, but not specificity, of a quantitative immunochemical fecal occult blood test for neoplasia is slightly increased by the use of low-dose aspirin, NSAIDs, and anticoagulants.

Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Maoz E, Birkenfeld S, Lieberman N, Klang S, Niv Y.

Am J Gastroenterol. 2009 Apr;104(4):933-8. doi: 10.1038/ajg.2009.14. Epub 2009 Mar 17.

PMID:
19293792
18.

Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood.

Rozen P, Waked A, Vilkin A, Levi Z, Niv Y.

Med Sci Monit. 2006 Jun;12(6):MT27-32. Epub 2006 May 29.

PMID:
16733493
19.

Quantitative colonoscopic evaluation of relative efficiencies of an immunochemical faecal occult blood test and a sensitive guaiac test for detecting significant colorectal neoplasms.

Rozen P, Levi Z, Hazazi R, Waked A, Vilkin A, Maoz E, Birkenfeld S, Niv Y.

Aliment Pharmacol Ther. 2009 Feb 15;29(4):450-7. doi: 10.1111/j.1365-2036.2008.03898.x. Epub 2008 Nov 17.

20.

A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population.

Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y.

Gastroenterology. 2005 Aug;129(2):422-8.

PMID:
16083699

Supplemental Content

Support Center